###begin article-title 0
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppt1 </italic>
###xml 62 72 62 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 62 72 <span type="species:ncbi:7227">Drosophila</span>
An over-expression system for characterizing Ppt1 function in Drosophila
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1 </italic>
The infantile onset form of Neuronal Ceroid Lipofuscinoses (INCL) is the earliest and most severe form of NCL, with neurological symptoms that reflect massive neurodegeneration in the CNS and retina. INCL is due to recessively inherited mutations at the CLN1 locus. This locus encodes the evolutionarily conserved enzyme palmitoyl-protein thioesterase 1 (PPT1), indicating an essential role for protein palmitoylation in normal neuronal function.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppt1 </italic>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppt1 </italic>
###xml 126 136 126 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 172 179 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 197 208 197 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 334 341 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 392 403 392 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1S123A</italic>
###xml 551 557 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 578 585 578 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 637 643 637 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 126 136 <span type="species:ncbi:7227">Drosophila</span>
###xml 197 207 <span type="species:ncbi:7227">Drosophila</span>
To begin to elucidate the specific role that Ppt1 plays in neuronal cells, we have developed a Ppt1 over-expression system in Drosophila. We report that over-expression of DmPpt1 in the developing Drosophila visual system leads to the loss of cells through apoptotic cell death. This DmPpt1 over-expression phenotype is suppressed by DmPpt1 genomic deficiencies. Moreover, over-expression of DmPpt1S123A, which bears a catalytic site serine 123 to alanine mutation, does not lead to the severe eye phenotype observed with over-expression of wild-type DmPpt1. Thus, cell loss in DmPpt1 flies is directly related to the dosage of wildtype DmPpt1.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 277 295 277 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila DmPpt1 </italic>
###xml 277 287 <span type="species:ncbi:7227">Drosophila</span>
Although INCL is due to the loss of PPT1; increased levels of DmPpt1 also lead to neurodegeneration possibly via a detrimental effect on some aspect of PPT1's normal function. This suggests that the precise levels of PPT1 activity are important for neuronal cell survival. The Drosophila DmPpt1 over-expression system provides a resource for genetic experiments that aim to identify the processes by which PPT1 regulates the palmitoylation-state of its essential protein substrates.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 627 633 627 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1-8</italic>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1 </italic>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN2 </italic>
###xml 822 833 822 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN 3, 5, 6</italic>
###xml 839 841 839 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8 </italic>
###xml 898 899 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
The most common of the pediatric neurodegenerative diseases (1 in 12,500 births) are a set of primarily recessive disorders termed Neuronal Ceroid Lipofuscinoses (NCLs) due to the loss of central nervous system neurons and the accumulation of auto-fluorescent lipopigment [1]. While most cells contain inclusions, neurons are primarily affected leading to symptoms that include loss of vision, motor dysfunction, intellectual decline, and seizures [2]. Each NCL subtype is classified by its characteristic membrane/protein lysosomal inclusion pathology and age of onset [2]. Genetic analysis of the NCLs has identified 8 loci, CLN1-8, that are associated with the differing ages of onset of the disorders. Six of the eight loci have been mapped showing that CLN1 and CLN2 encode soluble enzymes with known functions while CLN 3, 5, 6, and 8 are putative transmembrane proteins of unknown function [2].
###end p 8
###begin p 9
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1 </italic>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Infantile onset NCL (INCL) is the earliest and most severe form of NCL with symptoms that include loss of vision, motor dysfunction, intellectual decline, and seizures due to massive neurodegeneration in the CNS and retina [2]. INCL is caused by mutations in the CLN1 gene which encodes palmitoyl-protein thioesterase 1 (PPT1), suggesting that there is an important role for the regulation of palmitoylation in normal neuronal function [3]. This post-translation modification is the addition of a palmitate fatty acid chain to proteins. PPT1 is one of the enzymes that catalyze the removal of palmitoyl groups from specific protein targets. Unlike permanent fatty-acid chain additions, such as myristolation, palmitoylation is dynamic and very little is known about its role in the regulation of protein function [4].
###end p 9
###begin p 10
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 634 638 634 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ras </sup>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 345 348 <span type="species:ncbi:10116">rat</span>
Histochemical and biochemical analysis of PPT1 has shown that it appears to be present within the endo-lysosomal compartment and possibly in the cytoplasm [5-8]. Consistent with an important role for PPT1 in neurons, the protein is found with synaptic vesicles and synaptosomes in neuronal cell culture [9,10]. A model of excito-toxicity in the rat brain confirms a presynaptic localization for the protein and suggests that PPT1 may be neuro-protective during an excito-toxic event [11]. Finally, over-expression of PPT1 in a neuronal cell line protected cells from the induction of apoptosis suggesting that de-palmitoylation of p21Ras and other substrate proteins may play a role in the regulation of neural death [8]. While this recent work is beginning to shed light on the protein's function, there is still little understanding of the role PPT1 plays in different cellular compartments, including tissue specific substrates and signaling pathways that it may modulate.
###end p 10
###begin p 11
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 341 352 341 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 420 431 420 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 626 637 626 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 777 793 777 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila Ppt1 </italic>
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 341 351 <span type="species:ncbi:7227">Drosophila</span>
###xml 420 430 <span type="species:ncbi:7227">Drosophila</span>
###xml 603 608 <span type="species:ncbi:9606">human</span>
###xml 626 636 <span type="species:ncbi:7227">Drosophila</span>
###xml 777 787 <span type="species:ncbi:7227">Drosophila</span>
Drosophila has been an important model system for the study of human disease and has made important contributions to the understanding of several kinds of neuronal degeneration including Huntington's, Parkinson's, Alzheimer's, and Machado-Joseph Diseases [reviewed in [12,13] and references therein]. The powerful genetic tools available in Drosophila as well as the high degree of conservation of gene function between Drosophila and higher vertebrates makes it an ideal system to study the cellular function of PPT1. The adult visual system in particular has been especially useful for characterizing human disease genes in Drosophila and for identifying modifiers of their function. In this study we present the development of an over-expression system for the study of the Drosophila Ppt1 gene.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
Generation of DmPpt1 Over-expression Lines
###end title 13
###begin p 14
###xml 4 15 4 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 410 421 410 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 776 783 776 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 828 835 828 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 857 865 857 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 951 958 951 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 4 14 <span type="species:ncbi:7227">Drosophila</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 410 420 <span type="species:ncbi:7227">Drosophila</span>
The Drosophila PPT1 homolog (DmPpt1) is ~55% identical and ~74% similar to the human protein at the amino acid level [14]. The DmPpt1 transcript appears to be expressed ubiquitously at low levels during embryonic and larval development (data not shown). Consistent with the levels of mRNA, DmPpt1 enzymatic activity is present at varying levels in all tissues that have been tested [14]. In order to produce a Drosophila model to study PPT1 function, we generated 10 independent UAS:DmPpt1 insertion lines and used the GMR-Gal4 driver line to over-express DmPpt1 in the developing visual system. The GMR Gal4 driver expresses GAL4 in all cell types including neuronal photoreceptors as the eye differentiates during the larval and pupal stages [15]. We confirmed that the UAS:DmPpt1 overexpression lines did indeed over-express DmPpt1 message by performing in situ hybridizations on third instar eye imaginal discs (data not shown). Expression of the DmPpt1 transgene was consistent with the previously described GMR GAL4 expression pattern [15]. We were not able to analyze the levels of protein produced or subcellular localization of the over-expressed protein due to the lack of a specific antibody reagent.
###end p 14
###begin p 15
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 258 265 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 428 439 428 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A,1B,1C,1D</xref>
###xml 590 597 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1I</xref>
We analyzed the surface of the eyes in DmPpt1 over-expression adults with scanning electron microscopy (Figure 1) and at the light microscope level and found a range of morphological defects, both weak (Figure 1C) and strong (Figure 1D) depending on the UAS-DmPpt1 insertion line. The eyes show a change in size, a disruption of the individual ommatidia number and spacing as well as an absence of some sensory bristles (Figure 1A,1B,1C,1D), suggesting that there was cell loss occurring during the development of each ommatidium. Furthermore, when examined under the light microscope, the DmPpt1 over-expressing eyes contain black ommatidia (Figure 1I). These black spots do not form progressively over the life of the fly. Quantitative counting experiments over a 15 day period indicates that the number present at eclosion, while variable from fly to fly, is constant throughout the life of the individual fly (data not shown). The black spots, therefore, appear to be indicative of a degeneration event later in development once the eye has fully differentiated.
###end p 15
###begin title 16
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
DmPpt1 Over-expression Induces Cell Death
###end title 16
###begin p 17
###xml 501 520 501 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4/UAS:DmPpt1</italic>
###xml 520 523 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 733 746 733 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4/CyO </italic>
###xml 811 826 811 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1/CyO </italic>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1J</xref>
###xml 953 963 953 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 963 966 963 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1J</xref>
###xml 1211 1213 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1244 1254 1244 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 1254 1257 1254 1257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
To determine whether the underlying cellular architecture of the eye was compromised, we preformed semi-thin sections on several over-expression lines, one showing a weak phenotype and one showing a strong phenotype, along with control lines (GMR:Gal4 and UAS insertion lines alone). These analyses revealed a striking loss of photoreceptors and other cell types that was correlated with the severity of the external eye morphology. Photoreceptor cell loss was quantified in the weak phenotypic line (GMR:Gal4/UAS:DmPpt18.1) by counting individual rhabdomeres per ommatidia in semi-thin retinal sections. This quantification showed that the eyes had an average of 5.08 +/- 1.20 rhabdomeres/ommatidia (n= 266). This was compared to a GMR:Gal4/CyO control line with an average of 6.97 +/- 0.16 (n = 341) and to a UAS:DmPpt1/CyO control line with 7 rhabdomeres/ommatidia (n = 301) (Figure 1J). As indicated by the quantification, the weak phenotypic line, UAS:DmPpt18.1, showed less than the full complement of 7 rhabdomeres visible in a section of control eyes (Figure 1J). Furthermore, those photoreceptor cells that were missing rhabdomeres appeared highly pigmented suggesting they were undergoing cell death [16]. The strong phenotypic line, UAS:DmPpt12.1, was not analyzed in this manner due to the severity of the defects and the fact that almost all rhabdomeres were missing, precluding reliable quantification.
###end p 17
###begin p 18
###xml 158 168 158 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 168 172 168 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1 </sup>
###xml 189 199 189 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 199 203 199 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1 </sup>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 416 424 416 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A,2B,2C</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
We further analyzed the ultrastructure of the degenerating photoreceptor neurons with transmission electron microscopy (TEM) focusing on sections of the weak UAS:DmPpt18.1 line, the strong UAS:DmPpt12.1 line, and a control insertion alone line. TEM sections of UAS:DmPpt1 over-expression lines showed photoreceptor neurons that had become highly vacuolized with rhabdomeres in various stages of degeneration (Figure 2A,2B,2C). In a strong phenotypic line, this abnormal neuronal cell phenotype was more pronounced, with almost all ommatidia appearing highly pigmented, full of vacuoles and missing all of their rhabdomeres. This type of ultrastructural appearance is indicative of photoreceptors undergoing programmed cell death [16].
###end p 18
###begin p 19
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p35 </italic>
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 357 364 357 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 388 393 388 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D,2E</xref>
To further test the idea that the defects we observed in eye development were the result of apoptotic cell death, we examined whether the eye morphology phenotype is altered by the presence of the baculoviral anti-apoptotic protein p35 [17]. Co-expression of p35 and DmPpt1 using the GMR promoter significantly reduced the rough eye defects associated with DmPpt1 over-expression (Figure 2D,2E). This suggests that, consistent with our TEM analysis, the defects we see are due in large part to cells dying through apoptosis.
###end p 19
###begin title 20
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
DmPpt1 Over-expression Mechanism
###end title 20
###begin p 21
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 411 418 411 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 520 526 520 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
We took two approaches to address whether the abnormal eye phenotypes are a result of increased levels of wildtype DmPpt1 or are due to an ectopic, non-wildtype function of the protein. First, two independent deficiency chromosomes that remove the genomic region containing the DmPpt1 locus were crossed into the DmPpt1 over-expression background. The rough eye defects were suppressed when the dose ofwildtype DmPpt1 was decreased (Figure 3). This suggests that the defects are produced by increased levels of wildtype DmPpt1.
###end p 21
###begin p 22
###xml 132 139 132 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 268 277 268 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 319 332 319 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1-S123A </italic>
###xml 450 457 450 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 527 540 527 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1-S123A </italic>
###xml 551 559 551 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 642 655 642 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1-S123A </italic>
###xml 748 753 748 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A,4B</xref>
###xml 808 815 808 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 870 883 870 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1-S123A </italic>
###xml 912 917 912 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C,4D</xref>
###xml 991 1004 991 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1-S123A </italic>
###xml 1027 1033 1027 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 1033 1037 1033 1037 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1 </sup>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 1133 1135 1133 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
###xml 1144 1145 1144 1145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1313 1320 1313 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 1473 1480 1473 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 1507 1514 1507 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 1570 1576 1570 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 1646 1653 1646 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 196 202 <span type="species:ncbi:9913">Bovine</span>
In a second approach, we changed the catalytic serine at amino acid 123 to alanine (S123A) through site directed mutagenesis of the DmPpt1 cDNA. A similar mutation in the homologous amino acid in Bovine PPT1 produces an enzyme with severely reduced catalytic activity in vitro [18]. We isolated several independent UAS:DmPpt1-S123A insertion lines to test whether enzyme activity is required for the rough eye and black spot phenotypes observed with DmPpt1 over-expression. We confirmed that the transgenic lines overexpressed DmPpt1-S123A message by in situ hybridization of eye imaginal discs (data not shown). Over-expression of three UAS:DmPpt1-S123A lines with GMR-Gal4 yielded no observable abnormal phenotypes when analyzed with SEM (Figure 4A,4B). We further compared two of these lines to wild-type DmPpt1 over-expression by analyzing semi-thin sections of UAS:DmPpt1-S123A over-expressing eyes (Figure 4C,4D). For quantification, the number of rhabdomeres in each ommatidia of UAS:DmPpt1-S123A lines and the weak UAS:DmPpt18.1 phenotypic line were compared (Figure 4E). Our analysis of the two catalytic mutant lines, S123A1 and S123A4, showed that they possessed 6.54 +/-0.86 (n = 369) and 6.09 +/- 1.07 (n = 292) rhabdomeres per ommatidia, respectively. These data demonstrate that over-expression of DmPpt1 catalytic domain mutants slightly decreases the number of rhabdomeres per ommatidia compared to control eyes, but is not nearly as severe as even a weak DmPpt1 line. This, along with the DmPpt1 deficiencies, indicates that a majority of the abnormal DmPpt1-associated phenotypes that we observe are due to increased levels of DmPpt1 message that likely leads to increased wildtype protein activity.
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 151 160 151 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1/Ppt1</italic>
###xml 165 175 165 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 200 211 200 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 355 362 355 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 380 391 380 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 663 669 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 686 693 686 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 803 810 803 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 852 859 852 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1014 1021 1014 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 1322 1329 1322 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 1406 1412 1406 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 165 175 <span type="species:ncbi:7227">Drosophila</span>
###xml 200 210 <span type="species:ncbi:7227">Drosophila</span>
###xml 380 390 <span type="species:ncbi:7227">Drosophila</span>
In this study, we have presented and characterized the first system to study the function of the Infantile Neuronal Ceroid Lipofuscinosis (INCL) gene, CLN1/Ppt1, in Drosophila. This is also the first Drosophila model system designed to characterize the cellular function of a lysosomal enzyme. Specifically, we have shown that targeted over-expression of DmPpt1 in the developing Drosophila visual system leads to the loss of cells through apoptotic cell death both early in eye development (rough eye) and also after ommatidial differentiation has finished, yielding black ommatidial spots. This phenotype is directly related to the increased dosage of wildtype DmPpt1mRNA. First, the DmPpt1 over-expression phenotypes were suppressed by two genomic deficiencies that remove one copy of the endogenous DmPpt1 locus. Moreover, the over-expression of a DmPpt1 catalytic mutant, shown to have reduced catalytic activity [18], produces only a mild eye phenotype rather than the dramatic degeneration seen in wildtype DmPpt1 over-expression. The mild eye phenotype associated with the expression of the S123A catalytic mutant suggests that this mutation is not a null but instead severely reduces DmPpt1 function. Thus, while over-expression may lead to non-specific consequences, our data suggests that the eye phenotypes in DmPpt1 over-expression flies are primarily a result of over-expression of wild-type DmPpt1, implying a detrimental effect of increased catalytic activity on processes that are normally regulated by DmPpt1.
###end p 24
###begin p 25
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppt1 </italic>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 257 261 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 527 533 <span type="species:ncbi:9606">humans</span>
###xml 538 542 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
PPT1 is involved in the de-palmitoylation of substrate proteins. This function is clearly important to neuronal cells since loss of PPT1 function leads to massive degeneration of neurons in the central nervous system of INCL patients [2] and Ppt1 knock-out mice [19]. The presence of lipofuscin and the build-up of endo-lysosomal inclusions suggest that PPT1's function may lie in the regulated subcellular trafficking and degradation of palmitoylated proteins. While these pathological defects associated with loss of PPT1 in humans and mice have been thoroughly characterized, there is very little functional data about the specific cell biological role that this protein plays.
###end p 25
###begin p 26
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ras </sup>
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 181 187 181 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink">&#945; </sub>
###xml 252 260 248 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 269 271 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 299 303 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ras </sup>
###xml 411 414 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ras</sup>
###xml 459 460 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 526 530 522 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ras </sup>
###xml 583 587 579 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ras </sup>
###xml 637 638 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 710 717 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 660 670 <span type="species:ncbi:7227">Drosophila</span>
The protein was initially purified through its ability to de-palmitoylate p21Ras [5]. In vitro, PPT1 has been shown to de-palmitoylate specific peptides suggesting that GAP43, the Galpha subunit of heterotrimeric G-proteins, and rhodopsin are possible in vivo targets [20]. Further evidence that p21Ras may be an endogenous target was shown by the ability of over-expressed PPT1 to block apoptosis through a p21Ras-Akt-Caspase pathway in neuroblastoma cells [8]. This inhibition was coincident with a decreased presence of p21Ras at the membrane suggesting that PPT1 may regulate p21Ras signaling by modulating its palmitoylation state [8]. This suggests that Drosophila Ras may be a candidate modifier of the DmPpt1 over-expression phenotype.
###end p 26
###begin title 27
Conclusions
###end title 27
###begin p 28
###xml 489 500 489 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 706 714 706 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 753 759 753 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
###xml 426 434 <span type="species:ncbi:9606">patients</span>
###xml 489 499 <span type="species:ncbi:7227">Drosophila</span>
Our findings indicate that, while recessive mutations that severely decrease PPT1 cause neuronal cell death in INCL patients, increased levels of PPT1 can also lead to neurodegeneration, revealing that the precise level of PPT1 is important for neuronal cell survival. A deeper understanding of PPT1's normal cellular function may therefore be necessary to the success of treatment strategies that aim to replace PPT1 in INCL patients. The over-expression system that we have developed in Drosophila will provide an opportunity to elucidate the role of DmPpt1 in neuronal and non-neuronal cells. The identification of genetic modifiers of this visual system phenotype will facilitate the identification of in vivo substrates and signaling pathways that DmPpt1may modulate. The insights gained from these results will further the understanding of PPT1 function and the molecular etiology of INCL.
###end p 28
###begin title 29
Methods
###end title 29
###begin title 30
Fly Husbandry
###end title 30
###begin p 31
###xml 53 63 <span type="species:ncbi:7227">Drosophila</span>
All crosses were performed at 25degreesC on standard Drosophila media.
###end p 31
###begin title 32
Transgenic Line
###end title 32
###begin p 33
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppt1 </italic>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 359 365 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white </italic>
###xml 477 484 473 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 500 508 496 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 586 595 582 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
The full length Ppt1 cDNA was obtained from Research Genetics. It was initially identified as the EST GM14257 using the BDGP EST database. The cDNA was cloned into the EcoRI and XhoI sites of the pUAST expression vector [21]. Transgenic flies were produced by standard methods using the pP{Wc Delta2,3} helper plasmid. Transformants were identified using the white marker gene contained in the pUAST vector. We further confirmed that the transgenics lines were over-expressing DmPpt1 message through in situ hybridization on third instar eye imaginal discs. We used the GM14257 cDNA to in vitro transcribe sense and anti-sense RNAs that were then used as probes on fixed eye imaginal disc tissue.
###end p 33
###begin title 34
Ppt1 mutagenesis
###end title 34
###begin p 35
###xml 361 362 361 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 391 392 391 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
To produce the Serine 123 to Alanine mutation, we used PCR to change the Serine codon CTC to the Alanine codon CGC. We designed overlapping primers that contained the point mutation and used them in conjunction with two flanking primers to incorporate the mutation at Serine 123. The primers used were (the point mutation is indicated in bold): S123A1:CGCCTTGCGCGAATCCGATG; S123A2:CATCGGATTCGCGCAAGGCG.
###end p 35
###begin title 36
Scanning Electron Microscopy
###end title 36
###begin p 37
###xml 94 99 <span type="species:ncbi:4932">yeast</span>
Newly eclosed adults of the specified genotypes were collected and aged for several days in a yeast-free food vial. These flies were then taken through a series of ethanol dehydration steps. They were first placed in 25% ethanol and after a 12-hr incubation time they were moved to 50% ethanol. This process continued, through the following dilutions: 50, 75, 95, and 2 incubations in 100% ethanol. They were left in 100% ethanol and taken to the Northeastern Electron Microscopy facility to be critical point dried and sputter coated for scanning electron microscopy.
###end p 37
###begin title 38
Sectioning and Transmission Electron Microscopy
###end title 38
###begin p 39
###xml 330 331 330 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
Newly eclosed adults of the specified genotypes were collected, their heads were removed and then placed in a fixative solution (1% gluturaldehyde, 2% Paraformaldehyde 0.1 M Na Phosphate pH 7.4) for 1 hour at room temperature. The heads were then washed three times in 0.1 M Na Phosphate and post fixed in osmium tetroxide (2% OsO4, 0.1 M Na Phosphate pH 7.4) for 1 hour. Following the post fixation step, the heads were washed three times for 10 minutes each in 0.1 M Na Phosphate. They were then dehydrated with an ethanol series consisting of 5 minute incubations in 30%, 50%, 70%, 85%, 95% ethanol and 2 incubations in 100% ethanol for 10 minutes each. The heads were embedded in plastic. Semi-thin plastic sections were mounted and stained with Toludine blue. Thin EM sections were stained, mounted on grids and analyzed using a Transmission Electron Microscope.
###end p 39
###begin title 40
Photoreceptor Quantification
###end title 40
###begin p 41
###xml 194 202 194 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyO</italic>
###xml 208 218 208 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 222 235 222 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyO, GMR:Gal4</italic>
###xml 236 246 236 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 246 249 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 251 275 251 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4/UAS:DmPpt1S123A</italic>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 282 306 282 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4/UAS:DmPpt1S123A</italic>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
For each genotype, the number of rhabdomeres present in each ommatidia were counted for semi-thin sections of 2 independent eyes per genotype. The following genotypes were used in the analyses: GMR:Gal4/CyO, UAS:DmPpt18.1/CyO, GMR:Gal4/UAS:DmPpt18.1, GMR:Gal4/UAS:DmPpt1S123A1, and GMR:Gal4/UAS:DmPpt1S123A4. All slides were blinded before scoring.
###end p 41
###begin title 42
p35 and Deficiency Suppression
###end title 42
###begin p 43
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 94 114 94 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4, UAS:DmPpt1</italic>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 117 131 117 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+; UAS:DmPpt1</italic>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 134 137 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+ </italic>
###xml 149 169 149 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4, UAS:DmPpt1</italic>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 172 194 172 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/pGMR:p35 ; UAS:DmPpt1</italic>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+ </italic>
###xml 262 269 262 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppt1 </italic>
###xml 509 516 509 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 617 642 617 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+; GMR:Gal4, UAS:DmPpt1</italic>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 645 659 645 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+; UAS:DmPpt1</italic>
###xml 659 662 659 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 662 665 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+ </italic>
###xml 674 707 674 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Df(1)KA12/+; GMR:Gal4, UAS:DmPpt1</italic>
###xml 707 710 707 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 710 724 710 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+; UAS:DmPpt1</italic>
###xml 724 727 724 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 727 730 727 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+ </italic>
###xml 743 775 743 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Df(1)RA2/+; GMR:Gal4, UAS:DmPpt1</italic>
###xml 775 778 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 778 792 778 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+; UAS:DmPpt1</italic>
###xml 792 795 792 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 795 798 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+ </italic>
To determine the effect of p35 expression on the DmPpt1 over-expression phenotype we compared GMR:Gal4, UAS:DmPpt18.1/+; UAS:DmPpt12.1/+ (n = 12) to GMR:Gal4, UAS:DmPpt18.1/pGMR:p35 ; UAS:DmPpt12.1/+ (n = 11). To determine the effect of removing one copy of the DmPpt1 genomic locus on the over-expression phenotype, we obtained two deficiencies, Df(1)KA12 and Df(1)RA2, from the Bloomington Stock Center. We confirmed that they both removed the Ppt1 locus by performing quantitative southern blots using the DmPpt1 cDNA as a probe (data not shown). For the analysis, we collected and compare the following genotypes +/+; GMR:Gal4, UAS:DmPpt18.1/+; UAS:DmPpt12.1/+ (n = 6), Df(1)KA12/+; GMR:Gal4, UAS:DmPpt18.1/+; UAS:DmPpt12.1/+ (n = 5), and Df(1)RA2/+; GMR:Gal4, UAS:DmPpt18.1/+; UAS:DmPpt12.1/+ (n = 5). Newly eclosed adults of the specific genotypes for both experiments were collected and analyzed by SEM as described above.
###end p 43
###begin title 44
Authors' Contributions
###end title 44
###begin p 45
CK and MM conceived of the study and designed the experiments described. CK carried out all of the experiments and drafted the manuscript. MM played an advisory role as the project developed and edited the draft manuscript. All authors read and approved the final manuscript.
###end p 45
###begin title 46
Abbreviations
###end title 46
###begin p 47
NCL, Neuronal Ceroid Lipofuscinosis; INCL, Infantile Neuronal Ceroid Lipofuscinosis; PPT1, Palmitoyl Protein-thioesterase 1
###end p 47
###begin title 48
Acknowledgements
###end title 48
###begin p 49
###xml 321 331 <span type="species:ncbi:7227">Drosophila</span>
###xml 434 444 <span type="species:ncbi:7227">Drosophila</span>
###xml 523 533 <span type="species:ncbi:7227">Drosophila</span>
We would like to thank the members of the MacDonald Laboratory and Kristin White for helpful discussions during the completion of this work. We would also like to thank Bill Fowle at the Northeastern Electron Microscopy Lab for his advice and technical expertise in preparing tissue for SEM and TEM analysis and the CBRC Drosophila Core Facility for help in generating transgenic lines. Finally we want to acknowledge the Bloomington Drosophila Stock Center for providing several stocks used in this study and the Berkeley Drosophila Genome Project for providing cDNA clones. This work was supported by NIH grant NS033648.
###end p 49
###begin article-title 50
Batten's Disease: Past, Present, Future
###end article-title 50
###begin article-title 51
Neuronal Ceroid Lipofuscinoses: Classification and Diagnosis
###end article-title 51
###begin article-title 52
Mutations in the palmitoyl-protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis
###end article-title 52
###begin article-title 53
The dynamic role of palmitoylation in signal transduction
###end article-title 53
###begin article-title 54
Purification and Properties of a Palmitoyl-Protein Thioesterase That Cleaves Palmitate From H-Ras
###end article-title 54
###begin article-title 55
Lysosomal Targeting of Palmitoyl-protein Thioesterase
###end article-title 55
###begin article-title 56
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Palmitoyl protein thioesterase: evidence for Lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis
###end article-title 56
###begin article-title 57
Palmitoyl Protein Thioesterase 1 Protects Against Apoptosis Mediated by Ras-Akt-Caspase Pathway in Neuroblastoma Cells
###end article-title 57
###begin article-title 58
Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL)
###end article-title 58
###begin article-title 59
Palmitoyl Protein Thioesterase 1 is Targeted to the Axons in Neurons
###end article-title 59
###begin article-title 60
Status epilepticus induces changes in the expression and localization of endogenous palmitoyl-protein thioesterase 1
###end article-title 60
###begin article-title 61
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 45 55 <span type="species:ncbi:7227">Drosophila</span>
Modeling human neurodegenerative diseases in Drosophila: on a wing and a prayer
###end article-title 61
###begin article-title 62
Transgenic invertebrate models of age-associated neurodegenerative diseases
###end article-title 62
###begin article-title 63
###xml 20 30 <span type="species:ncbi:7227">Drosophila</span>
Characterization of Drosophila palmitoyl-protein thioesterase 1
###end article-title 63
###begin article-title 64
###xml 86 96 <span type="species:ncbi:7227">Drosophila</span>
Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye
###end article-title 64
###begin article-title 65
###xml 34 44 <span type="species:ncbi:7227">Drosophila</span>
Rpr- and hid-driven cell death in Drosophila photoreceptors
###end article-title 65
###begin article-title 66
###xml 53 63 <span type="species:ncbi:7227">Drosophila</span>
Expression of baculovirus p35 prevents cell death in Drosophila
###end article-title 66
###begin article-title 67
The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis
###end article-title 67
###begin article-title 68
###xml 77 81 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice
###end article-title 68
###begin article-title 69
In vitro depalmitoylation of neurospecific peptides: implication for infantile neuronal ceroid lipofuscinosis
###end article-title 69
###begin article-title 70
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
###end article-title 70
###begin title 71
Figures and Tables
###end title 71
###begin p 72
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 126 133 126 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 321 329 320 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 330 333 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyO</italic>
###xml 344 354 343 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 354 357 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 358 363 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyO. </italic>
###xml 372 380 371 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 381 391 380 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 391 394 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 405 413 404 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 414 424 413 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 424 427 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 462 470 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 471 481 470 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 481 485 480 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1 </sup>
###xml 606 614 605 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 615 625 614 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 625 629 624 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1 </sup>
###xml 653 661 652 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 662 666 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyO </italic>
###xml 670 680 669 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 680 683 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 684 688 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyO </italic>
Analysis of DmPpt1 over-expression phenotypes. A-D, Scanning Electron Micrographs showing the external surface of control and DmPpt1 over-expression eyes (200x). E-H, Semi-thin sections through fixed retinal tissue showing the internal structure of control and DmPpt1 over-expression retinas. Scale bar = 2 mum. A and E, GMR:Gal4/CyO. B and F, UAS:DmPpt18.1/CyO. C and G, GMR:Gal4/UAS:DmPpt18.1. D and H, GMR:Gal4/UAS:DmPpt12.1. I, A light microscope image of a GMR:Gal4/UAS:DmPpt18.1 eye showing the black ommatidia present in the fully differentiated eye. J. Quantification of the loss of rhabdomeres in GMR:Gal4/UAS:DmPpt18.1 eyes in relation to the GMR:Gal4/CyO and UAS:DmPpt18.1/CyO controls. *p < .00001 using Ttest.
###end p 72
###begin p 73
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 101 111 101 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyO </italic>
###xml 198 206 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 207 217 206 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 217 221 216 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1 </sup>
###xml 357 365 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4</italic>
###xml 366 376 364 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS:DmPpt1</italic>
###xml 376 379 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 546 566 543 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4, UAS:DmPpt1</italic>
###xml 566 569 563 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 569 583 566 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+; UAS:DmPpt1</italic>
###xml 583 586 580 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 586 589 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+ </italic>
###xml 638 658 635 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4, UAS:DmPpt1</italic>
###xml 658 661 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 661 683 658 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/pGMR:p35 ; UAS:DmPpt1</italic>
###xml 683 686 680 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 686 689 683 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+ </italic>
DmPpt1 over-expressing eyes undergo apoptotic cell death. A-C, Transmission electron micrographs. A, UAS:DmPpt18.1/CyO control showing normal ommatidial structure. Scale bar = 2 mum. B, An image of GMR:Gal4/UAS:DmPpt18.1 over-expression ommatidium showing individual degenerating photoreceptors (labeled with an asterisk). Scale bar = 1 mum. C, An image of GMR:Gal4/UAS:DmPpt12.1over-expression ommatidium showing all photoreceptor undergoing cell death with no rhabdomeres present. Scale bar = 1 mum. D, Scanning electron micrograph (200x) of a GMR:Gal4, UAS:DmPpt18.1/+; UAS:DmPpt12.1/+ eye. E, Scanning electron micrograph (200x) of a GMR:Gal4, UAS:DmPpt18.1/pGMR:p35 ; UAS:DmPpt12.1/+ eye.
###end p 73
###begin p 74
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1 </italic>
###xml 121 146 121 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">+/+; GMR:Gal4, UAS:DmPpt1</italic>
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 149 163 149 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+; UAS:DmPpt1</italic>
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 166 169 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+ </italic>
###xml 181 214 181 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Df(1) RA2/+; GMR:Gal4, UAS:DmPpt1</italic>
###xml 214 217 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 217 231 217 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+; UAS:DmPpt1</italic>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 234 236 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+</italic>
###xml 241 275 241 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Df(1) KA12/+; GMR:Gal4, UAS:DmPpt1</italic>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1</sup>
###xml 278 292 278 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+; UAS:DmPpt1</italic>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2.1</sup>
###xml 295 297 295 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/+</italic>
Deficiency chromosome suppression of the DmPpt1 over-expression phenotype. A-C, Scanning electron micrographs (200x). A, +/+; GMR:Gal4, UAS:DmPpt18.1/+; UAS:DmPpt12.1/+ control. B, Df(1) RA2/+; GMR:Gal4, UAS:DmPpt18.1/+; UAS:DmPpt12.1/+. C, Df(1) KA12/+; GMR:Gal4, UAS:DmPpt18.1/+; UAS:DmPpt12.1/+.
###end p 74
###begin p 75
###xml 12 24 12 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1S123A </italic>
###xml 188 212 187 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4/UAS:DmPpt1S123A</italic>
###xml 212 213 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 224 248 223 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GMR:Gal4/UAS:DmPpt1S123A</italic>
###xml 248 249 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 315 327 314 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1S123A </italic>
###xml 360 366 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DmPpt1</italic>
###xml 366 370 365 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.1 </sup>
Analysis of DmPpt1S123A catalytic mutant over-expression. A-B, Scanning electron micrographs (200x). C-D, Light microscope images of semi-thin retinal sections. Scale bar= 2 mum. A and C, GMR:Gal4/UAS:DmPpt1S123A1. B and D, GMR:Gal4/UAS:DmPpt1S123A4. E. Quantification of the number of rhabdomeres per ommatidia in DmPpt1S123A over-expression eyes compared to DmPpt18.1 over-expression eyes. *p < .00001 by Ttest.
###end p 75

